Found in Translation. Soluble ST2 and Heart Disease

Journal of the American College of Cardiology

Volumn 55, Issue 3, 2010, Pages 251-253

  Moore, Stephanie A ^a   Januzzi Jr , James L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

aldosterone; cardiac magnetic resonance; myocardial infarction; remodeling; ST2

Indexed keywords

ALDOSTERONE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; CREATINE KINASE MB; EPLERENONE; INTERLEUKIN 33; INTERLEUKIN RECEPTOR; LIGAND; NATRIURETIC FACTOR; NORADRENALIN; PLACEBO; ST2 PROTEIN; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ALDOSTERONE BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CREATINE KINASE BLOOD LEVEL; DISEASE COURSE; ECHOCARDIOGRAPHY; EDITORIAL; GENETIC TRANSCRIPTION; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE SIZE; HEART PROTECTION; HEART VENTRICLE EJECTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HORMONAL REGULATION; HUMAN; IN VIVO STUDY; MUSCLE CELL; NORADRENALIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SOLUBILITY; UPREGULATION;

BIOLOGICAL MARKERS; HUMANS; INTERLEUKINS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RECEPTORS, CELL SURFACE; REPRODUCIBILITY OF RESULTS; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 73549087237     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.08.049     Document Type: Editorial

References (12)

1. Weir R.A.P., Miller A.M., Murphy G.E.J., et al. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coll Cardiol 55 (2010) 243-250
2. Kakkar R., and Lee R.T. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7 (2008) 827-840
3. Weinberg E.O., Shimpo M., De Keulenaer G.W., et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106 (2002) 2961-2966
4. Sanada S., Hakuno D., Higgins L.J., Schreiter E.R., McKenzie A.N., and Lee R.T. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117 (2007) 1538-1549
5. Shah R.V., Chen-Tournoux A.A., Picard M.H., van Kimmenade R.R., and Januzzi J.L. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Circ Heart Fail 2 (2009) 311-319
6. Boisot S., Beede J., Isakson S., et al. Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure. J Card Fail 14 (2008) 732-738
7. Januzzi Jr. J.L., Peacock W.F., Maisel A.S., et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol 50 (2007) 607-613
8. Rehman S.U., Mueller T., and Januzzi Jr. J.L. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 52 (2008) 1458-1465
9. Sabatine M.S., Morrow D.A., Higgins L.J., et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 117 (2008) 1936-1944
10. Shimpo M., Morrow D.A., Weinberg E.O., et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109 (2004) 2186-2190
11. Weinberg E.O., Shimpo M., Hurwitz S., Tominaga S., Rouleau J.L., and Lee R.T. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107 (2003) 721-726
12. Iraqi W., Rossignol P., Angioi M., et al. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study. Circulation 119 (2009) 2471-2479